Does CEMIPLIMAB Cause Basal cell carcinoma? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Basal cell carcinoma have been filed in association with CEMIPLIMAB (LIBTAYO). This represents 0.6% of all adverse event reports for CEMIPLIMAB.
6
Reports of Basal cell carcinoma with CEMIPLIMAB
0.6%
of all CEMIPLIMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Basal cell carcinoma From CEMIPLIMAB?
Of the 6 reports.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for CEMIPLIMAB.
What Other Side Effects Does CEMIPLIMAB Cause?
Fatigue (68)
Pyrexia (49)
Pneumonia (41)
Dyspnoea (40)
Pneumonitis (38)
Off label use (35)
Diarrhoea (34)
Rash (34)
Cytokine release syndrome (33)
Pain (33)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which CEMIPLIMAB Alternatives Have Lower Basal cell carcinoma Risk?
CEMIPLIMAB vs CEMIPLIMAB-RWLC
CEMIPLIMAB vs CENEGERMIN-BKBJ
CEMIPLIMAB vs CENOBAMATE
CEMIPLIMAB vs CEPHALEXIN
CEMIPLIMAB vs CERITINIB